Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 4/20 | 0.38 |
| ▸ | LMNA | P02545 | 4/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | CA12 | O43570 | 4/20 | 0.36 |
| ▸ | CA1 | P00915 | 4/20 | 0.36 |
| ▸ | CA2 | P00918 | 4/20 | 0.36 |
| ▸ | CA9 | Q16790 | 4/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | HMGCR | P04035 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL517978 | 0.85 | GAA (0.43) | GAAMEN1KMT2AALDH1A1 | |
| SCHEMBL11673488 | 0.80 | ALOX15 (0.31) | — | |
| SCHEMBL518054 | 0.74 | POLB (0.38) | POLBGAALMNANPSR1MEN1 | |
| SCHEMBL517581 | 0.71 | POLB (0.33) | POLBGAALMNANPSR1KMT2A | |
| SCHEMBL11316425 | 0.69 | CA12 (0.48) | POLBGAALMNANPSR1MEN1 | |
| SCHEMBL11143647 | 0.69 | POLB (0.64) | POLBGAALMNANPSR1MEN1 | |
| SCHEMBL518217 | 0.68 | POLB (0.44) | POLBGAALMNANPSR1MEN1 | |
| SCHEMBL5394331 | 0.68 | GAA (0.38) | POLBGAALMNANPSR1MEN1 | |
| SCHEMBL7187493 | 0.68 | PTPN1 (0.37) | POLBGAALMNANPSR1MEN1 | |
| SCHEMBL21722914 | 0.68 | NPSR1 (0.56) | POLBGAALMNANPSR1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120029224-A1 | PROCESS FOR THE PREPARATION OF HALOGENATED ARYL PHOSPHONATES | BROMINE COMPOUNDS LTD. (IL) | 2012-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029224-A1 | PROCESS FOR THE PREPARATION OF HALOGENATED ARYL PHOSPHONATES | PIK3CA, PIP5K1B, PIP5K1C | POLB 1353/4885GAA 4294/4885LMNA 1460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.